TRIPLE MARKER SCREEN
| The Triple Screen test is used for Prenatal Screening of Down Syndrome (Trisomy 21), Edward’s Syndrome (Trisomy 18) and Open Neural Tube Defects. The approximate detection rate with this test is 55–65% with a false positive rate of 5% |
Pre-test Information : Test is valid between 14-22 weeks gestation (Ideal 15-20 weeks). Provide maternal Date of birth (dd/mm/yy); LMP or Ultrasound; IVF, Number of Fetuses (Single/ Twins); Diabetic status and Body Weight in Kg, Smoking & Previous history of Trisomy 21 pregnancy |
|---|
Report Delivery : Next Day |
Components in test : 3 |
TRIPLE MARKER SCREEN
| Test Code | T-32 |
|---|---|
| Test Description | **TRIPLE MARKER SCREEN |
| COMPONENTS | AFP, uE3 And Beta HCG wth graph and Risk Evaluation |
| Clinical Category | Prenatal Diagnosis |
| Sample | 3 mL (1.5 mL min.) serum . Provide maternal Date of birth (dd/mm/yy); LMP or Ultrasound; IVF, Number of Fetuses (Single/ Twins); Diabetic status and Body Weight in Kg, Smoking & Previous history of Trisomy 21 pregnancy in Maternal Serum Screen Form. Valid between 14-22 weeks gestation (Ideal 15-20 weeks) |
| Method/Technology | Chemiluminescent Immunoassay |
| Storage/Temp | |
| Reporting Time | NEXT DAY |